M. Relf

The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.

G. Stamp, P. Allavena, A. Mantovani, 1995, The Journal of clinical investigation.

A cytokine profile of normal and malignant ovary.

F. Balkwill, F. Burke, R. Negus, 1996, Cytokine.

Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.

J. Uhr, G. Janossy, P. Knowles, 1988, Cancer research.

Evaluation of four CD22 antibodies as ricin a chain‐containing immunotoxins for the in vivo therapy of human B‐cell leukemias and lymphomas

J. Uhr, G. Janossy, P. Knowles, 1988, International journal of cancer.

New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.

D. Blakey, P. Knowles, P. Thorpe, 1987, Cancer research.

Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes

S. Fox, A. Harris, R. Leek, 1997, Cancer research.

Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer

A. Harris, R. Leek, R. Bicknell, 1994, Cancer.

Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkages.

D. Newell, D. Blakey, P. Knowles, 1988, Cancer research.